MAP3K1 and non-small cell lung carcinoma: Non-small cell lung carcinoma (NSCLC) cell-derived extracellular vesicular miR-770 has been confirmed to inhibit M2 macrophage polarization by targeting MAP3K1, which in turn prevents tumor invasion (72).